FORBES.COM BIOTECH NEWSLETTER OCTOBER 19, 2005 | |
Biotech Investors Rotate Into Pharma Gurus Fly High With Bird Flu Stocks 10.18.05, 2:06 PM ET - Marketocracy's top pickers harvest oil-patch profits and buy companies positioned to fight the avian flu. Eye On Stocks Health Health | |
Forbes Magazine Special Offer!Forbes.com Newsletter readers receive a Free Trial Issue of Forbes... no risk... no obligation! If you decide to subscribe to Forbes, you can do so at special introductory savings, and get 25 more issues - 26 in all - for just $1.15 a copy. You save 77% off the $4.99 newsstand price. If you decide Forbes is not for you, simply write cancel on the invoice you receive and return it. The FREE issue is yours to keep with our compliments. Sign up Today for your Free Trial Issue! Unsubscribing from a newsletterThis e-mail is sent to you because you selected to receive Forbes.com Newsletters. To unsubscribe from this newsletter, please reply to this e-mail with UNSUBSCRIBE in the subject field. To MANAGE all your Forbes.com newsletter accounts or change your delivery address, click here.If you have questions or need help, please contact Forbes.com customer service at customerservice@forbes.net or send your request in the mail directly to: Forbes.com, Inc. To review our privacy policy, click here. Special Reports © 2005 Forbes.com Inc.™ | |
|
|
||||||||||||||||||||||||||||||||
Biotech: Biotech Investors Rotate Into Pharma
by
Alex Hsieh on behalf of Professor Henry Wang
on Wed 19 Oct 2005 10:28 PM EDT | Permanent Link
| Cosmos
No comments found.
Trackbacks
TrackBack URL: Weblogs that reference this article:
|
Search
Links
|
|||||||||||||||||||||||||||||||
